Latest filing published 28 Jun 2021 for Pharma-Bio Serv, Inc., €106.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elizabeth Plaza: trading record in brief
Elizabeth Plaza is a declared insider of Pharma-Bio Serv, Inc. (chief executive), with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 9 July 2008 and the latest from 25 June 2021.
Market trades split into 1 purchase (€346k) and 4 sales (€229k). Purchases outweigh sales by €117k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. 2021 to date brings no purchases and 4 sales.
The record was last updated on 28 June 2021 with an open-market sale (€106) in Pharma-Bio Serv, Inc. The last purchase on record was published on 31 December 2009, which is 6,157 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elizabeth Plaza
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$1.270.8% of flowCommon StockSEC:0001104659-21-086414:0
- 4,000 shares@ US$1.271.9% of flowCommon StockSEC:0001104659-21-085532:1
- 12,220 shares@ US$1.318999.2% of flowCommon StockSEC:0001104659-21-085532:0
- 230,000 shares@ US$1.1092.2% of flowCommon StockSEC:0001104659-21-039813:0
- 2,482,574 shares@ US$0.20Common StockSEC:0001144204-09-067012:0Canonical exit: 29 Mar 2010 (T+90)
- 466,667 shares@ US$0.7344Common StockSEC:0001144204-08-039548:0
6 of 6 declarations